Patent · US Active

Pyridone GPR119 G protein-coupled receptor agonists

US8003796B2 · kind B2 · utility

1Cited by

9References

20Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Dean A. Wacker · Chadds Ford, US
Karen A. Rossi · Newtown, US
Ying Wang · Chengdu, CN

Key dates

Filing date	Jul 16, 2008
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Feb 23, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. These novel compounds have the structure Formula I or Formula IA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.